2-157766005-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PS1PM2PM5PP3_StrongPP5_Moderate
The NM_001111067.4(ACVR1):c.982G>A(p.Gly328Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G328E) has been classified as Pathogenic.
Frequency
Consequence
NM_001111067.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 328 of the ACVR1 protein (p.Gly328Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with fibrodysplasia ossificans progressiva (PMID: 19085907). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 29593). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ACVR1 function (PMID: 22977237, 29307777). This variant disrupts the p.Gly328 amino acid residue in ACVR1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19085907, 29307777, 31012264, 33973349). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Progressive myositis ossificans Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at